Kasinger James R.
CRISPR Therapeutics AG-Common Shares · General Counsel and Secretary
Kasinger James R. is listed in filings as General Counsel and Secretary at CRISPR Therapeutics AG-Common Shares. This profile follows SEC Form 4 activity through Jun 2, 2026, including sale activity. Recent filings connect the profile to CRISPR Therapeutics AG-Common Shares (CRSP). The current snapshot covers public activity from Oct 15, 2024 to Jun 2, 2026. Reported amounts are shown as $148.9K to $166.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $166k3.5k shares | SellMar 16, 2026 | $48.26 | $47.58 | |
| $148k2.8k shares | SellMar 11, 2026 | $52.80 | $47.58 | |
| $111k2.1k shares | SellFeb 19, 2026 | $52.58 | $47.58 | |
| $72k1.1k shares | SellOct 14, 2025 | $66.60 | $47.58 | |
| $131k3.2k shares | SellMar 21, 2025 | $41.23 | $47.58 | |
| $48k1.1k shares | SellMar 12, 2025 | $43.32 | $47.58 | |
| $121k2.9k shares | SellMar 11, 2025 | $42.42 | $47.58 | |
| $103k1.9k shares | SellFeb 19, 2025 | $52.80 | $47.58 | |
| $517k9.6k shares | SellFeb 18, 2025 | $53.85 | $47.58 | |
| $50k1.1k shares | SellOct 14, 2024 | $46.28 | $47.58 |